THTX
$3.50
Theratechnologies
($.03)
(.85%)
THTX
Earnings Whisper ®
N/A
4th Quarter November 2021
Consensus:  $0.00
Revenue:  N/A
Wednesday
Jan 12
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when THTX reports earnings?
Beat
Meet
Miss

Where is THTX's stock price going from here?
Up
Flat
Down
Stock chart of THTX
Analysts
Summary of analysts' recommendations for THTX
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
Theratechnologies, Inc. is a pharmaceutical company focusing on the development of therapeutic peptide products with an emphasis on growth-hormone releasing factor peptides. It's main product EGRIFTA is used for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy which is marketed primarily in the United States, Latin America, Africa, the Middle East, Europe, Russia, South Korea, Taiwan, and Thailand. Theratechnologies, Inc. is headquartered in Montreal, Canada.